Histidine 375 modulates CD4 binding in HIV-1 CRF01_AE envelope glycoproteins

Journal of Virology

Volumn 91, Issue 4, 2017, Pages

  Zoubchenok, Daria ^a,b   Veillette, Maxime ^a,b   Prévost, Jérémie ^a,b   Sanders Buell, Eric ^c,d   Wagh, Kshitij ^e   Korber, Bette ^e   Chenine, Agnès L ^c,d   Finzi, Andrés ^a,b,f  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^e LOS ALAMOS NATIONAL LABORATORY   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

CD4; CRF01_AE; Env; Gp120; HIV 1; Inner domain layers; Phe43 cavity

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; HISTIDINE; PHENYLALANINE; SERINE; PROTEIN BINDING;

AMINO ACID ANALYSIS; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CELL FUSION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; VIRUS ENVELOPE; AMINO ACID SUBSTITUTION; CELL LINE; CHEMISTRY; CLASSIFICATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MUTATION; PHYLOGENY; VIROLOGY; VIRUS ATTACHMENT; VIRUS ENTRY;

AMINO ACID SUBSTITUTION; ANTIGENS, CD4; CELL LINE; HISTIDINE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; PHYLOGENY; PROTEIN BINDING; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 85012023574     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02151-16     Document Type: Article

References (60)

1. Mansky LM, Temin HM. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69:5087-5094.
2. O'Neil PK, Sun G, Yu H, Ron Y, Dougherty JP, Preston BD. 2002. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem 277:38053-38061. https://doi.org/10.1074/jbc.M204774200.
3. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH. 2010. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol 84:9864-9878. https://doi.org/10.1128/JVI.00915-10.
4. Coffin JM. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489. https://doi.org/10.1126/science.7824947.
5. Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, Little SJ, Richman DD. 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A 102:18514-18519. https://doi.org/10.1073/pnas.0504658102.
6. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126. https://doi.org/10.1038/373123a0.
7. McCutchan FE. 2006. Global epidemiology of HIV. J Med Virol 78(Suppl 1):S7-S12. https://doi.org/10.1002/jmv.20599.
8. Burke DS. 1997. Recombination in HIV: an important viral evolutionary strategy. Emerg Infect Dis 3:253-259. https://doi.org/10.3201/eid0303.970301.
9. Taylor BS, Hammer SM. 2008. The challenge of HIV-1 subtype diversity. N Engl J Med 359:1965-1966. https://doi.org/10.1056/NEJMc086373.
10. Hemelaar J. 2012. The origin and diversity of the HIV-1 pandemic. Trends Mol Med 18:182-192. https://doi.org/10.1016/j.molmed.2011.12.001.
11. Hemelaar J. 2013. Implications of HIV diversity for the HIV-1 pandemic. J Infect 66:391-400. https://doi.org/10.1016/j.jinf.2012.10.026.
12. Saksena NK, Lau KA, Dwyer DE, Wang B. 2011. HIV recombination and pathogenesis-biological and epidemiological implications, HIV and AIDS-updates on biology, immunology, epidemiology and treatment strategies. InTech https://doi.org/10.5772/23819.
13. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. 2000. HIV-1 nomenclature proposal. Science 288:55-56.
14. Zhang M, Foley B, Schultz AK, Macke JP, Bulla I, Stanke M, Morgenstern B, Korber B, Leitner T. 2010. The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 7:25. https://doi.org/10.1186/1742-4690-7-25.
15. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, Wolinsky S, Bhattacharya T. 2000. Timing the ancestor of the HIV-1 pandemic strains. Science 288:1789-1796. https://doi.org/10.1126/science.288.5472.1789.
16. Hu WS, Temin HM. 1990. Retroviral recombination and reverse transcription. Science 250:1227-1233. https://doi.org/10.1126/science.1700865.
17. Temin HM. 1991. Sex and recombination in retroviruses. Trends Genet 7:71-74.
18. Li X, Li W, Zhong P, Fang K, Zhu K, Musa TH, Song Y, Du G, Gao R, Guo Y, Yan W, Xuan Y, Wei P. 2016. Nationwide trends in molecular epidemiology of HIV-1 in China. AIDS Res Hum Retroviruses 32:851-859. https://doi.org/10.1089/AID.2016.0029.
19. Hemelaar J, Gouws E, Ghys PD, Osmanov S. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13-W23. https://doi.org/10.1097/01.aids.0000247564.73009.bc.
20. Carr JK, Salminen MO, Koch C, Gotte D, Artenstein AW, Hegerich PA, St Louis D, Burke DS, McCutchan FE. 1996. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 70:5935-5943.
21. Simon-Loriere E, Galetto R, Hamoudi M, Archer J, Lefeuvre P, Martin DP, Robertson DL, Negroni M. 2009. Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog 5:e1000418. https://doi.org/10.1371/journal.ppat.1000418.
22. Archer J, Pinney JW, Fan J, Simon-Loriere E, Arts EJ, Negroni M, Robertson DL. 2008. Identifying the important HIV-1 recombination breakpoints. PLoS Comput Biol 4:e1000178. https://doi.org/10.1371/journal.pcbi.1000178.
23. Finzi A, Xiang SH, Pacheco B, Wang L, Haight J, Kassa A, Danek B, Pancera M, Kwong PD, Sodroski J. 2010. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. Mol Cell 37:656-667. https://doi.org/10.1016/j.molcel.2010.02.012.
24. Helseth E, Olshevsky U, Furman C, Sodroski J. 1991. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J Virol 65: 2119-2123.
25. Yang X, Mahony E, Holm GH, Kassa A, Sodroski J. 2003. Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits. Virology 313: 117-125. https://doi.org/10.1016/S0042-6822(03)00273-3.
26. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-659. https://doi.org/10.1038/31405.
27. Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. 1995. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 69:5723-5733.
28. Lu M, Blacklow SC, Kim PS. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 2:1075-1082. https://doi.org/10.1038/nsb1295-1075.
29. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387:426-430. https://doi.org/10.1038/387426a0.
30. Xiang SH, Kwong PD, Gupta R, Rizzuto CD, Casper DJ, Wyatt R, Wang L, Hendrickson WA, Doyle ML, Sodroski J. 2002. Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol 76:9888-9899. https://doi.org/10.1128/JVI.76.19.9888-9899.2002.
31. Desormeaux A, Coutu M, Medjahed H, Pacheco B, Herschhorn A, Gu C, Xiang SH, Mao Y, Sodroski J, Finzi A. 2013. The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions. J Virol 87:2549-2562. https://doi.org/10.1128/JVI.03104-12.
32. Finzi A, Pacheco B, Xiang SH, Pancera M, Herschhorn A, Wang L, Zeng X, Desormeaux A, Kwong PD, Sodroski J. 2012. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding. J Virol 86:8974-8986. https://doi.org/10.1128/JVI.01076-12.
33. Li H, Wang S, Kong R, Ding W, Lee FH, Parker Z, Kim E, Learn GH, Hahn P, Policicchio B, Brocca-Cofano E, Deleage C, Hao X, Chuang GY, Gorman J, Gardner M, Lewis MG, Hatziioannou T, Santra S, Apetrei C, Pandrea I, Alam SM, Liao HX, Shen X, Tomaras GD, Farzan M, Chertova E, Keele BF, Estes JD, Lifson JD, Doms RW, Montefiori DC, Haynes BF, Sodroski JG, Kwong PD, Hahn BH, Shaw GM. 2016. Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques. Proc Natl Acad Sci U S A 113: E3413-E3422. https://doi.org/10.1073/pnas.1606636113.
34. Ding S, Medjahed H, Prevost J, Coutu M, Xiang SH, Finzi A. 2016. Lineage-specific differences in the gp120 inner domain layer 3 of human and simian immunodeficiency viruses. J Virol 90:10065-10073. https://doi.org/10.1128/JVI.01215-16.
35. Sharp PM, Hahn BH. 2011. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 1:a006841. https://doi.org/10.1101/cshperspect.a006841.
36. Zhong P, Pan Q, Ning Z, Xue Y, Gong J, Zhen X, Zhou L, Sheng F, Zhang W, Gai J, Cheng H, Yue Q, Xing H, Zhuang M, Lu W, Shao Y, Kang L. 2007. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 23:847-856. https://doi.org/10.1089/aid.2006.0196.
37. He X, Xing H, Ruan Y, Hong K, Cheng C, Hu Y, Xin R, Wei J, Feng Y, Hsi JH, Takebe Y, Shao Y, Group for HIVMES. 2012. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One 7:e47289. https://doi.org/10.1371/journal.pone.0047289.
38. Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA, Subbarao S, Parekh BS, Srisuwanvilai L, Sutthent R, Wasi C, Heneine W, Choopanya K. 2001. Viral load differences in early infection with two HIV-1 subtypes. AIDS 15:683-691. https://doi.org/10.1097/00002030-200104130-00003.
39. Rangsin R, Piyaraj P, Sirisanthana T, Sirisopana N, Short O, Nelson KE. 2007. The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up. AIDS 21(Suppl 6):S39-S46.
40. Rangsin R, Chiu J, Khamboonruang C, Sirisopana N, Eiumtrakul S, Brown AE, Robb M, Beyrer C, Ruangyuttikarn C, Markowitz LE, Nelson KE. 2004. The natural history of HIV-1 infection in young Thai men after seroconversion. J Acquir Immune Defic Syndr 36:622-629. https://doi.org/10.1097/00126334-200405010-00011.
41. Mao Y, Wang L, Gu C, Herschhorn A, Xiang SH, Haim H, Yang X, Sodroski J. 2012. Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. Nat Struct Mol Biol 19:893-899. https://doi.org/10.1038/nsmb.2351.
42. Kang CY, Hariharan K, Nara PL, Sodroski J, Moore JP. 1994. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. J Virol 68:5854-5862.
43. Myszka DG, Sweet RW, Hensley P, Brigham-Burke M, Kwong PD, Hendrickson WA, Wyatt R, Sodroski J, Doyle ML. 2000. Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A 97:9026-9031. https://doi.org/10.1073/pnas.97.16.9026.
44. Kwon YD, Finzi A, Wu X, Dogo-Isonagie C, Lee LK, Moore LR, Schmidt SD, Stuckey J, Yang Y, Zhou T, Zhu J, Vicic DA, Debnath AK, Shapiro L, Bewley CA, Mascola JR, Sodroski JG, Kwong PD. 2012. Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl Acad Sci U S A 109:5663-5668. https://doi.org/10.1073/pnas.1112391109.
45. Veillette M, Desormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, Haynes BF, Robinson JE, Kaufmann DE, Bonsignori M, Sodroski J, Finzi A. 2014. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibodydependent cell-mediated cytotoxicity. J Virol 88:2633-2644. https://doi.org/10.1128/JVI.03230-13.
46. Wyatt R, Sodroski J. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888. https://doi.org/10.1126/science.280.5371.1884.
47. Haim H, Si Z, Madani N, Wang L, Courter JR, Princiotto A, Kassa A, DeGrace M, McGee-Estrada K, Mefford M, Gabuzda D, Smith AB, III, Sodroski J. 2009. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. PLoS Pathog 5:e1000360. https://doi.org/10.1371/journal.ppat.1000360.
48. Haim H, Strack B, Kassa A, Madani N, Wang L, Courter JR, Princiotto A, McGee K, Pacheco B, Seaman MS, Smith AB, III, Sodroski J. 2011. Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity. PLoS Pathog 7:e1002101. https://doi.org/10.1371/journal.ppat.1002101.
49. Mori K, Rosenzweig M, Desrosiers RC. 2000. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages. J Virol 74:10852-10859. https://doi.org/10.1128/JVI.74.22.10852-10859.2000.
50. Marcon L, Choe H, Martin KA, Farzan M, Ponath PD, Wu L, Newman W, Gerard N, Gerard C, Sodroski J. 1997. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J Virol 71:2522-2527.
51. Marcon L, Sodroski J. 1997. High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain. AIDS Res Hum Retroviruses 13:441-447. https://doi.org/10.1089/aid.1997.13.441.
52. LaBonte JA, Patel T, Hofmann W, Sodroski J. 2000. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells. J Virol 74: 10690-10698. https://doi.org/10.1128/JVI.74.22.10690-10698.2000.
53. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72: 2855-2864.
54. Korber B, Foley BT, Kuiken C, Pillai SK, Sodroski JG. 1998. Numbering positions in HIV relative to HXB2CG. https://hfv.lanl.gov/content/sequence/HIV/COMPENDIUM/1998/III/HXB2.pdf.
55. Rho HM, Poiesz B, Ruscetti FW, Gallo RC. 1981. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology 112:355-360. https://doi.org/10.1016/0042-6822(81)90642-5.
56. Coutu M, Finzi A. 2015. HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands. J Virol Methods 215-216:37-44. https://doi.org/10.1016/j.jviromet.2015.02.017.
57. Johnsson B, Lofas S, Lindquist G. 1991. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198: 268-277. https://doi.org/10.1016/0003-2697(91)90424-R.
58. Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res 14:1188-1190. https://doi.org/10.1101/gr.849004.
59. Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C, Carlson J, Yusim K, McMahon B, Gaschen B, Mallal S, Mullins JI, Nickle DC, Herbeck J, Rousseau C, Learn GH, Miura T, Brander C, Walker B, Korber B. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315:1583-1586. https://doi.org/10.1126/science.1131528.
60. Gnanakaran S, Daniels MG, Bhattacharya T, Lapedes AS, Sethi A, Li M, Tang H, Greene K, Gao H, Haynes BF, Cohen MS, Shaw GM, Seaman MS, Kumar A, Gao F, Montefiori DC, Korber B. 2010. Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput Biol 6:e1000955. https://doi.org/10.1371/journal.pcbi.1000955.